$AKTS has received 3 mentions from 2 distinct FinTwit voices over the past 12 months, with the biotech category dominating discussion. @jacobplieth led engagement with 2 mentions, followed by @aleabitoreddit with 1 mention. The ticker first appeared in the archive on December 22, 2025, with the most recent mention on March 24, 2026. Initial discussion centered on the company's IPO valuation, with @jacobplieth noting first-day trading performance and comparing $AKTS's $140 million in private funding to competitor Eikon's $800 million. Subsequent mentions positioned $AKTS within broader federal funding narratives, identifying the company as a lead grant recipient for the "LADDER" project via the NEMC Hub with $4 million in DoD microelectronics support.